Dynamic Cross-Correlation Matrix (DCCM) Reveals New Insights to Discover New NLRP3 Inhibitors Useful as Anti-Inflammatory Drugs
The innate immune system is responsible for the body’s defense against aggressive agents, mainly through activating pattern-recognition receptors (PRRs). Recognizing these agents results in an inflammatory response that activates tissue repair and eliminates the agent. Among the macromolecules relat...
Main Authors: | Igor José dos Santos Nascimento, Marianny De Souza, Daniel Calazans Medeiros, Ricardo Olimpio de Moura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Medical Sciences Forum |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-9992/14/1/84 |
Similar Items
-
The α-Synuclein Monomer May Have Different Misfolding Mechanisms in the Induction of α-Synuclein Fibrils with Different Polymorphs
by: Nannan Zhao, et al.
Published: (2023-04-01) -
A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
by: Callum AH Docherty, et al.
Published: (2023-01-01) -
Editorial: NLRP3 Inflammasome: Regulatory Mechanisms, Role in Health and Disease and Therapeutic Potential
by: Oleg V. Chernikov, et al.
Published: (2021-09-01) -
Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives and Analogs Targeting the NLRP3 Inflammasome
by: Liangkun Pan, et al.
Published: (2017-01-01) -
Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
by: Abbas Khan, et al.
Published: (2020-01-01)